SCHEMBL657387

SCHEMBL657387

CCOC(=O)C(C(=O)OCC)C(CC(=O)c1ccc2ccccc2c1)c1ccc2ccccc2c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDPK1 O15530 1/20 0.58
NPC1 O15118 4/20 0.46
ALDH1A1 P00352 3/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
RAB9A P51151 2/20 0.46
CYP2D6 P10635 2/20 0.46
SLC6A2 P23975 2/20 0.46
SLC6A4 P31645 2/20 0.46
SLC6A3 Q01959 2/20 0.46
KCNH2 Q12809 2/20 0.46
GAA P10253 5/20 0.45
MGAM O43451 4/20 0.45
SI P14410 4/20 0.45
MGAM2 Q2M2H8 4/20 0.45
HPGD P15428 4/20 0.45
KMT2A Q03164 3/20 0.45
KDM4E B2RXH2 3/20 0.45
MEN1 O00255 2/20 0.45
PTPN1 P18031 1/20 0.44
MAPT P10636 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL656638 0.94 PDPK1 (0.53) PDPK1NPC1ALDH1A1SMN1; SMN2RAB9A
SCHEMBL657195 0.84 PDPK1 (0.49) PDPK1NPC1ALDH1A1SMN1; SMN2RAB9A
SCHEMBL657072 0.84 ALDH1A1 (0.51) PDPK1NPC1ALDH1A1GAAMGAM
SCHEMBL657675 0.83 PDPK1 (0.81) PDPK1NPC1ALDH1A1SMN1; SMN2RAB9A
SCHEMBL657948 0.81 PDPK1 (0.50) PDPK1NPC1ALDH1A1SMN1; SMN2RAB9A
SCHEMBL5106153 0.80 NPC1 (0.51) NPC1ALDH1A1SMN1; SMN2RAB9AGAA
SCHEMBL659187 0.80 PDPK1 (0.74) PDPK1ALDH1A1CYP2D6SLC6A2SLC6A4
SCHEMBL7153178 0.79 SLC6A2 (0.48) PDPK1CYP2D6SLC6A2SLC6A4SLC6A3
SCHEMBL657975 0.78 PDPK1 (0.69) PDPK1SMN1; SMN2CYP2D6SLC6A2SLC6A4
SCHEMBL7109210 0.78 KMT2A (0.67) PDPK1NPC1ALDH1A1SMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2349999-B1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIV SAARLAND (DE) 2016-01-27 EP disclosed
US-8912186-B2 Allosteric protein kinase modulators UNIVERSITAET DES SAARLANDES (DE) 2014-12-16 US disclosed
US-20120046307-A1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIVERSITAET DES SAARLANDES (DE) 2012-02-23 US disclosed
EP-2349999-A1 ALLOSTERIC PROTEIN KINASE MODULATORS Universität des Saarlandes (DE) 2011-08-03 EP disclosed
WO-2010043711-A1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIVERSITAET DES SAARLANDES (DE) 2010-04-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046307-A1 ALLOSTERIC PROTEIN KINASE MODULATORS AURKC, AURKA, AURKB PDPK1 109/4885NPC1 2687/4885ALDH1A1 4784/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.